The history of Viagra, initially marketed by copyright, presents a fascinating case study for investors considering the healthcare landscape . Despite its early success and impact of billions in earnings , the intellectual property lapse has opened the floodgates for competing medications, substantially diminishing earnings opportunities. This tran